Editorial

View All
Your Trusted Source for Biopharma News
Editorial The CMC Challenge of Scaling Cell and Gene Therapies

Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core constraint is not steel and glass. It is biology, variability, and a regulatory environment that requires…

Seven Biopharma Trends to Watch in 2026
EditorialSeven Biopharma Trends to Watch in 2026

The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at

From Breakthroughs to Scale: Biopharma Platforms Shaping 2026
EditorialFrom Breakthroughs to Scale: Biopharma Platforms Shaping 2026

In 2026, boards and customers are asking a direct question: can promising science be turned into

How Will the Global Obesity Market Accelerate Through 2026?
EditorialHow Will the Global Obesity Market Accelerate Through 2026?

The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as

Biopharma Shifts Strategy Amid Global Headwinds
EditorialBiopharma Shifts Strategy Amid Global Headwinds

The End of the Old Biopharma Playbook The biopharmaceutical industry is confronting a structural

View All

Research & Development

View All
View All

Tech & Innovation

View All
View All
Is SuperAging Simply the Absence of Alzheimer’s Risk?
Tech & Innovation Is SuperAging Simply the Absence of Alzheimer’s Risk?

The prevailing narrative of human aging has long depicted a slow and inevitable erosion of cognitive faculties, yet a remarkable demographic known as SuperAgers continues to defy these expectations by maintaining memory performance typical of individuals decades younger. These unique individuals,

LITMUS Study Validates Imaging Endpoints for MASLD Trials
Tech & InnovationLITMUS Study Validates Imaging Endpoints for MASLD Trials

The clinical research community has long grappled with the invasive necessity of liver biopsies,

Optimizing Clinical Trial Per-Patient Costs in 2026
Tech & InnovationOptimizing Clinical Trial Per-Patient Costs in 2026

The financial architecture of modern drug development has undergone a radical transformation,

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later